By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > GMJ Briefs > UK Health Officials Issue Guidance on Andes Hantavirus Following South American Outbreaks
Health PolicyPolicy & Systems

UK Health Officials Issue Guidance on Andes Hantavirus Following South American Outbreaks

GMJ
Last updated: 15/06/2026 13:23
By
Prof. Giorgi Pkhakadze
Share
1 Min Read
SHARE
3 min read|590 words
✓ Editorially Reviewed by Prof. Giorgi Pkhakadze, MD, MPH, PhD — GMJ News Desk

🟠 Moderate Evidence

UK health authorities have published comprehensive guidance on Andes hantavirus following increased surveillance of the pathogen in South American regions. The UK Health Security Agency guidance addresses epidemiological patterns, clinical management, and diagnostic protocols for this potentially fatal rodent-borne virus.

Key takeaways

  • Andes hantavirus causes hantavirus pulmonary syndrome with case fatality rates reaching 40%
  • Transmission occurs through inhalation of aerosolised rodent excreta, primarily from long-tailed pygmy rice rats
  • Person-to-person transmission has been documented, unlike other hantavirus strains
40%
case fatality rate for Andes hantavirus pulmonary syndrome

Epidemiological patterns emerge across South America

Andes hantavirus demonstrates distinct geographical distribution across Argentina, Chile, Bolivia, and southern Brazil, according to the US Centers for Disease Control and Prevention. The virus primarily circulates among long-tailed pygmy rice rats (Oligoryzomys longicaudatus), with human infections occurring through inhalation of virus-contaminated aerosols from rodent urine, droppings, or saliva.

Unlike other hantavirus species, Andes virus exhibits documented person-to-person transmission capabilities, particularly in household settings. This unique characteristic has prompted enhanced surveillance protocols among international health authorities.

Submit Your Paper
GMJ_Submit_Banner

Andes Hantavirus Geographic Distribution

Primary endemic regions in South America

Argentina
High
Chile
Moderate
Bolivia
Limited
Brazil (South)
Sporadic

Source: UK Health Security Agency, 2024 | Georgian Medical Journal News

Clinical presentation and diagnostic challenges

Hantavirus pulmonary syndrome typically presents with a prodromal phase characterised by fever, myalgia, and gastrointestinal symptoms lasting 3-5 days. The World Health Organization describes rapid progression to cardiopulmonary phase with capillary leak syndrome and acute respiratory distress.

Diagnosis relies on serological testing, including IgM ELISA and RT-PCR methods. The UK guidance emphasises the importance of travel history screening for patients presenting with compatible symptoms who have visited endemic regions within the preceding six weeks.

Person-to-person transmission of Andes virus occurs in approximately 20% of household contacts during acute illness

— UK Health Security Agency Epidemiological Review (2024)

Prevention and control measures

Prevention strategies focus on reducing rodent exposure in endemic areas through environmental management and personal protective measures. The CDC recommends sealing holes and gaps in homes, removing potential nesting sites, and using appropriate respiratory protection when cleaning potentially contaminated areas.

Healthcare workers managing suspected cases should implement contact and droplet precautions due to documented human-to-human transmission potential. The guidance emphasises early recognition and supportive care as primary therapeutic interventions, given the absence of specific antiviral treatments or vaccines.

What this means

For patients: Travellers to South America should avoid rodent-infested areas and seek immediate medical attention for fever and respiratory symptoms within six weeks of return
For clinicians: Maintain high index of suspicion for hantavirus in patients with compatible symptoms and relevant travel history; implement appropriate isolation precautions
For policymakers: Enhanced surveillance systems and diagnostic capabilities are essential for early detection and outbreak response in endemic regions

Frequently asked questions

How is Andes hantavirus transmitted?

Transmission occurs primarily through inhalation of aerosolised rodent excreta from infected long-tailed pygmy rice rats. Unlike other hantaviruses, person-to-person transmission has been documented in household settings.

What are the symptoms of hantavirus pulmonary syndrome?

Initial symptoms include fever, muscle aches, and gastrointestinal problems, followed by rapid onset of breathing difficulties and fluid accumulation in the lungs. The case fatality rate can reach 40%.

Is there treatment available for Andes hantavirus?

No specific antiviral therapy or vaccine exists for Andes hantavirus. Treatment focuses on supportive care, particularly respiratory and cardiovascular support in intensive care settings.

The publication of this guidance reflects growing international concern about hantavirus emergence and the need for coordinated surveillance efforts. As climate change and ecological disruption potentially expand rodent habitats, health authorities emphasise the importance of maintaining diagnostic capabilities and clinical awareness for this severe respiratory pathogen.

Source: Andes hantavirus: epidemiology, outbreaks and guidance

Was this article helpful?

Related Coverage

Insulin Remains Inaccessible to Millions Despite Century of ProgressJun 15, 2026
Eswatini Targets Malaria Elimination by 2028 as WHO Reports 2.3 Billion Cases Averted Since 2000Jun 15, 2026
MHRA Reports Progress on Health Equity Through Regulatory ReformJun 15, 2026
FDA Issues 47 Medical Device Safety Alerts in 2024, Highlighting Critical Patient Safety RisksJun 15, 2026
Related reference
  • Iron · Ingredient
TAGGED:hantavirusInfectious Diseasepublic healthrespiratory syndromeUK guidance
Share This Article
Facebook LinkedIn Bluesky Copy Link Print
GMJ
ByProf. Giorgi Pkhakadze
Follow:
Prof. Giorgi Pkhakadze, MD, MPH, PhD, is Editor-in-Chief of the Georgian Medical Journal and Chair of the Public Health Institute of Georgia (PHIG). He is Professor and Head of the Department of Social and Behavioural Sciences at David Tvildiani Medical University, and Secretary/Treasurer of the UEMS Section of Public Health. ORCID: 0000-0001-7609-4515.

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
Breakthrough Drug Targeting ‘Undruggable’ KRAS Mutation Nearly Doubles Pancreatic Cancer Survival

New targeted therapy daraxonrasib successfully inhibits KRAS mutations in pancreatic cancer, nearly…

Large Brazilian Study Links Table Salt Habits to Cognitive Decline in 8,300 Older Adults

A comprehensive study of 8,300 older Brazilian adults found that men are…

Prenatal Zika exposure linked to vision, hearing deficits despite apparently healthy births

New research reveals that infants with prenatal Zika exposure develop vision, hearing,…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Global HealthPolicy & Systems

WHO Declares Public Health Emergency as Ebola Crosses DRC-Uganda Border

By
Prof. Giorgi Pkhakadze
31/05/2026
Global HealthPolicy & Systems

WHO Declares Public Health Emergency for Cross-Border Ebola Outbreak in DRC and Uganda

By
Prof. Giorgi Pkhakadze
31/05/2026
Global HealthPolicy & Systems

Ebola Outbreak in Congo Surpasses 900 Cases, WHO Confirms 220 Deaths

By
Prof. Giorgi Pkhakadze
26/05/2026
Global HealthPolicy & Systems

UK Issues New Guidance on Andes Hantavirus as South American Cases Rise

By
Prof. Giorgi Pkhakadze
14/06/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up